D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$408M |
| 2 |
Medtronic
MDT
|
+$271M |
| 3 |
NXP Semiconductors
NXPI
|
+$270M |
| 4 |
Gilead Sciences
GILD
|
+$253M |
| 5 |
Hewlett Packard
HPE
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$424M |
| 2 |
CVS Health
CVS
|
+$391M |
| 3 |
LNKD
LinkedIn Corporation
LNKD
|
+$323M |
| 4 |
Wells Fargo
WFC
|
+$280M |
| 5 |
VMW
VMware, Inc
VMW
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.54% |
| 2 | Healthcare | 10.14% |
| 3 | Financials | 8.94% |
| 4 | Consumer Discretionary | 8.18% |
| 5 | Industrials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Patterson-UTI
PTEN
$3.57B
| $2.99M | 0.01% |
111,102
-24,511
| -18% | -$605K |
|
1677
Beazer Homes USA
BZH
$887M
| $2.99M | 0.01% |
224,745
-323,215
| -59% | -$3.99M |
|
|
GG
1678
DELISTED
Goldcorp Inc
GG
| $2.98M | 0.01% |
219,357
-191,328
| -47% | -$2.67M |
|
1679
CALL
Thor Industries
THO
$4.04B
| $2.98M | 0.01% |
29,800
-1,800
| -6% | -$162K |
|
|
VR
1680
DELISTED
Validus Hold Ltd
VR
| $2.98M | 0.01% |
54,149
+30,629
| +130% | +$1.62M |
|
|
HF
1681
DELISTED
HFF Inc.
HF
| $2.98M | 0.01% |
98,424
+86,101
| +699% | +$2.45M |
|
1682
Wipro
WIT
$19.1B
| $2.97M | 0.01% |
1,637,157
+54,245
| +3% | +$97.3K |
|
1683
Bio-Rad Laboratories Class A
BIO
$8.8B
| $2.96M | 0.01% |
16,239
-1,618
| -9% | -$276K |
|
1684
AB InBev
BUD
$163B
| $2.96M | 0.01% |
28,082
-325,957
| -92% | -$36.5M |
|
1685
iShares MSCI Australia ETF
EWA
$1.38B
| $2.95M | 0.01% |
145,938
+29,188
| +25% | +$601K |
|
1686
CALL
Raymond James Financial
RJF
$33.7B
| $2.95M | 0.01% |
+63,900
| New | +$2.82M |
|
1687
PUT
Simon Property Group
SPG
$76.7B
| $2.95M | 0.01% |
+16,600
| New | +$3.08M |
|
1688
PUT
Vertex Pharmaceuticals
VRTX
$125B
| $2.95M | 0.01% |
40,000
+27,700
| +225% | +$2.25M |
|
1689
LivaNova
LIVN
$4.5B
| $2.95M | 0.01% |
65,521
-204,776
| -76% | -$10.1M |
|
1690
Boyd Gaming
BYD
$6.71B
| $2.94M | 0.01% |
+145,760
| New | +$2.81M |
|
1691
Hancock Whitney
HWC
$6.22B
| $2.94M | 0.01% |
68,200
-70,769
| -51% | -$2.69M |
|
1692
CALL
Cracker Barrel
CBRL
$1.26B
| $2.94M | 0.01% |
+17,600
| New | +$2.66M |
|
1693
Rush Enterprises Class A
RUSHA
$6.32B
| $2.93M | 0.01% |
206,978
+86,558
| +72% | +$1.07M |
|
|
NXGN
1694
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.93M | 0.01% |
223,102
+35,901
| +19% | +$460K |
|
|
UNT
1695
DELISTED
UNIT Corporation
UNT
| $2.93M | 0.01% |
109,134
+71,430
| +189% | +$1.54M |
|
1696
PUT
United Therapeutics
UTHR
$25.9B
| $2.93M | 0.01% |
20,400
| – | – |
|
1697
CALL
Weibo
WB
$1.98B
| $2.93M | 0.01% |
72,080
-5,800
| -7% | -$277K |
|
1698
Materion
MTRN
$4.01B
| $2.92M | 0.01% |
73,734
+3,884
| +6% | +$137K |
|
1699
ePlus
PLUS
$2.45B
| $2.92M | 0.01% |
101,284
+53,552
| +112% | +$1.39M |
|
1700
PUT
Acadia Pharmaceuticals
ACAD
$4.45B
| $2.92M | 0.01% |
101,100
+31,100
| +44% | +$823K |
|
Similar funds
D.E. Shaw & Co's Q4 2016 Portfolio in Review
As of Q4 2016, D.E. Shaw & Co held 3,804 positions worth $58.9B, up 3.9% from $56.7B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
D.E. Shaw & Co's Q4 2016 filing shows 462 new, 1,382 increased, 1,255 reduced and 397 closed positions. Its largest new stake was Deere & Co: 1,429,259 shares worth $147M. The largest sale was Amazon, an estimated $424M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2016 buy was Deere & Co: 1,429,259 shares worth $147M.
- D.E. Shaw & Co added most to Netflix in Q4 2016, an estimated $408M increase.
- D.E. Shaw & Co's biggest Q4 2016 reduction was Amazon, cutting an estimated $424M.
- D.E. Shaw & Co fully exited LinkedIn Corporation in Q4 2016, selling an estimated $323M.
- D.E. Shaw & Co's ten largest holdings make up 8.8% of its $58.9B portfolio in Q4 2016.
- D.E. Shaw & Co opened 462 new positions and closed 397 in Q4 2016.
- D.E. Shaw & Co's portfolio value rose 3.9% quarter-over-quarter to $58.9B.
Based on D.E. Shaw & Co's 13F filing for Q4 2016, filed 14 Feb 2017.